PharmaDrug: Cepharanthine Identified For Potential To Bind To Monkeypox Proteins In Independent Screening

PharmaDrug (CSE: PHRX) is reporting this morning that cepharanthine, of which their subsidiary has developed a patented version with enhanced oral bioavailability, has been highlighted as having the potential to bind to monkeypox proteins following an independent screening of drugs to treat the disease.

Read more

PharmaDrug Joint Venture Receives Approval For Phase 1 Clinical Trial

Pharmadrug Inc (CSE: PHRX) has received approval for its majority owned joint venture, Sairiyo Therapeutics, to process with a Phase 1 clinical study in Australia. The trial aims to assess a reformulated version of oral cepharanthine, referred to as PD-001, as a treatment for cancer and medical countermeasures.

Read more

Is Cocaine Turning The Tide Towards Legalization?

Switzerland is currently reevaluating its stance on drug policy as reports emerge of a groundbreaking proposal to legalize the sale of cocaine for recreational use in the capital city of Bern. This comes in response to mounting evidence suggesting that the country’s longstanding “war on drugs” has proven ineffective.

Read more